Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcimona cells

Journal of Antibiotics

Volumn 53, Issue 10, 2000, Pages 1191-1200

  Kim, Y B ^a   Ki, S W ^a   Yoshida, M ^a   Horinouchi, S ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BROXURIDINE; CELL CYCLE PROTEIN; CHYMOTRYPSIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; DEPSIPEPTIDE; DNA; ENZYME ANTIBODY; ENZYME INHIBITOR; FR 901228; FRUCTOSE BISPHOSPHATE ALDOLASE; FUNGAL PROTEIN; HISTONE; HISTONE DEACETYLASE; OVALBUMIN; PHOSPHOPROTEIN; PROTEIN CDC25A; PROTEIN P21; RETINOBLASTOMA PROTEIN; TETRAPEPTIDE; TRANSCRIPTION FACTOR E2F; TRAPOXIN A; TRICHOSTATIN A; TYLOXAPOL; UNCLASSIFIED DRUG;

ACETYLATION; ALLELE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G1 PHASE; COLORECTAL CARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GEL FILTRATION CHROMATOGRAPHY; GENE OVEREXPRESSION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; UTERINE CERVIX CARCINOMA;

EID: 0033767848     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.1191     Document Type: Article

References (26)

1. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A
2. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
3. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase
4. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
5. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines
6. Roles of histone acetyltransferases and deacetylases in gene regulation
7. Retinoblastoma protein recruits histone deacetylase to repress transcription
8. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
9. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
10. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
11. The retinoblastoma protein and cell cycle control
12. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity
13. A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay
14. Redistribution of the CDK inhibitor p27 between different cyclin. CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation
15. Human papillomavirus E6 and E7: Proteins which deregulate the cell cycle
16. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15
17. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition
18. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase
19. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells
20. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate
21. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals
22. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific Chromatin acetylation and antiproliferative effects
23. Regulation of the cyclin E gene by transcription factor E2F1
24. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site
25. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter
26. Control of E2F activity by p21 Waf1/Cip1